Oligodendroglioma
📧 Sign up to get email alerts when something new happens for Oligodendroglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Everolimus in Treating Patients With Recurrent Low-Grade Glioma [Phase 2]
Phase 2 clinical trial of everolimus in adults with recurrent low-grade glioma has completed; results were posted in 2019.
-
CLINICAL_TRIALS research · 2019-02-21Clinical Trial Update: A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas [Phase 2]
A Phase 2 prospective cohort study evaluating the effect of temozolomide on IDH-mutant low-grade gliomas (astrocytoma, oligodendroglioma, an…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Yoga Therapy in Treating Patients With Malignant Brain Tumors [NA]
This entry notes a terminated clinical trial at Wake Forest evaluating yoga therapy for adults with malignant brain tumors.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Perampanel in Seizure Patients With Primary Glial Brain Tumors [Phase 4]
Phase 4 study of perampanel for seizures in patients with primary glial brain tumors completed; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma [Phase 2]
A Phase 2 trial of antineoplaston therapy for recurrent or refractory oligodendroglioma was terminated, and the study results were posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-06-08Clinical Trial Update: The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas
This document reports an update on using APT MRI to predict Bevacizumab efficacy in patients with recurrent malignant gliomas; the trial sta…
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors [NA]
A clinical trial evaluating 68Ga-DOTATOC PET-CT for brain tumors in children and young adults has been withdrawn from the study.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases [NA]
A clinical trial comparing gadobutrol to gadopentetate dimeglumine or gadobenate dimeglumine before DCE-MRI in patients with multiple sclero…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas [NA]
Terminated trial evaluating 18F-FDOPA PET/CT or PET/MRI for measuring tumors in patients with newly diagnosed or recurrent gliomas; results …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors [Phase 2]
Phase 2 trial evaluating bevacizumab with or without trebananib for recurrent brain tumors has completed enrollment with results posted.
-
CLINICAL_TRIALS withdrawal · 2017-02-20Clinical Trial Update: Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas [EARLY_Phase 1]
Early-phase trial evaluating autologous stem cell collection and reinfusion in newly diagnosed high-grade gliomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]
Clinical trial update for Temsirolimus and Perifosine in recurrent or progressive malignant glioma (Phase 1/2) with completed status and pos…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors [Phase 1]
Phase 1 study of AZD2171 (cediranib) in children with recurrent, progressive, or refractory primary central nervous system tumors has comple…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Sunitinib in Treating Patients With Recurrent Malignant Gliomas [Phase 2]
Phase 2 trial evaluating sunitinib for adults with recurrent malignant gliomas has completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas [EARLY_Phase 1]
An early Phase 1 trial evaluating an HLA-A2-restricted glioma antigen-peptide vaccine with Poly-ICLC in recurrent WHO Grade II gliomas (astr…
-
CLINICAL_TRIALS research · 2015-09-22Clinical Trial Update: FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
Update on a clinical trial evaluating FET-PET imaging for diagnosis and monitoring of low-grade gliomas, including astrocytoma, oligodendrog…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma [Phase 2]
Phase 2 trial of sunitinib malate in children with recurrent, refractory, or progressive malignant gliomas and ependymomas has completed; re…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
This completed clinical trial examined the natural history of brain function, quality of life, and seizure control in adults with brain tumo…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor [Phase 1, Phase 2]
Phase 1/2 trial evaluating imatinib mesylate for recurrent brain tumors completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Treatment Strategy for Low-grade Gliomas [Phase 3]
A Phase 3 trial for low-grade gliomas has been terminated, involving astrocytoma, oligodendroglioma, and oligoastrocytoma.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma [Phase 2]
This Phase 2 clinical trial evaluates the efficacy of protracted temozolomide in patients with progressive high-grade glioma, including glio…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma [Phase 2]
Phase 2 clinical trial update evaluating tipifarnib in pediatric patients with recurrent or progressive brain tumors has completed, reportin…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Cilengitide in Treating Children With Refractory Primary Brain Tumors [Phase 1]
Phase 1 trial of cilengitide in children with refractory primary brain tumors has completed; the study explored safety, dosing, and tolerabi…
-
FDA approval · 2013-08-15FDA Approved: GLEOSTINE — Supplemental Application (NextSource Biotechnology, LLC)
The FDA approved a supplemental application for Gleostine (lomustine) submitted by NextSource Biotechnology, LLC.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating combination chemotherapy with bone marrow or peripheral stem cell…